Literature DB >> 23205844

Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach.

Agnies M van Eeghen1, Margaret B Pulsifer, Vanessa L Merker, Ann M Neumeyer, Elmer E van Eeghen, Ronald L Thibert, Andrew J Cole, Fawn A Leigh, Scott R Plotkin, Elizabeth A Thiele.   

Abstract

AIM: As relationships between autistic traits, epilepsy, and cognitive functioning remain poorly understood, these associations were explored in the biologically related disorders tuberous sclerosis complex (TSC), neurofibromatosis type 1 (NF1), and epilepsy.
METHOD: The Social Responsiveness Scale (SRS), a quantitative measure of autistic traits, was distributed to caregivers or companions of patients with TSC, NF1, and childhood-onset epilepsy of unknown cause (EUC), and these results were compared with SRS data from individuals with idiopathic autism spectrum disorders (ASDs) and their unaffected siblings. Scores and trait profiles of autistic features were compared with cognitive outcomes, epilepsy variables, and genotype.
RESULTS: A total of 180 SRS questionnaires were completed in the TSC, NF1, and EUC outpatient clinics at the Massachusetts General Hospital (90 females, 90 males; mean age 21 y, range 4-63 y), and SRS data from 210 patients with ASD recruited from an autism research collaboration (167 males, 43 females; mean age 9 y, range 4-22 y) and 130 unaffected siblings were available. Regression models showed a significant association between SRS scores and intelligence outcomes (p<0.001) and various seizure variables (p<0.02), but not with a specific underlying disorder or genotype. The level of autistic features was strongly associated with intelligence outcomes in patients with TSC and epilepsy (p<0.01); in patients with NF1 these relationships were weaker (p=0.25). For all study groups, autistic trait subdomains covaried with neurocognitive comorbidity, with endophenotypes similar to that of idiopathic autism.
INTERPRETATION: Our data show that in TSC and childhood-onset epilepsy, the severity and phenotype of autistic features are inextricably linked with intelligence and epilepsy outcomes. Such relationships were weaker for individuals with NF1. Findings suggest that ASDs are not specific in these conditions. © The Authors. Developmental Medicine & Child Neurology
© 2012 Mac Keith Press.

Entities:  

Mesh:

Year:  2012        PMID: 23205844      PMCID: PMC4071146          DOI: 10.1111/dmcn.12044

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  43 in total

1.  Lack of association of the (AAAT)6 allele of the GXAlu tetranucleotide repeat in intron 27b of the NF1 gene with autism.

Authors:  S M Plank; S A Copeland-Yates; K Sossey-Alaoui; J M Bell; R J Schroer; C Skinner; R C Michaelis
Journal:  Am J Med Genet       Date:  2001-07-08

2.  Intelligence in individuals with a neurofibromatosis type 1 microdeletion.

Authors:  M J Descheemaeker; K Roelandts; T De Raedt; H Brems; J P Fryns; E Legius
Journal:  Am J Med Genet A       Date:  2004-12-15       Impact factor: 2.802

3.  Reciprocal social behavior in children with and without pervasive developmental disorders.

Authors:  J N Constantino; T Przybeck; D Friesen; R D Todd
Journal:  J Dev Behav Pediatr       Date:  2000-02       Impact factor: 2.225

Review 4.  Depression and anxiety in epilepsy.

Authors:  M J Jackson; D Turkington
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

5.  Autism in tuberous sclerosis complex.

Authors:  G C Gutierrez; S L Smalley; P E Tanguay
Journal:  J Autism Dev Disord       Date:  1998-04

6.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

7.  Intergenerational transmission of subthreshold autistic traits in the general population.

Authors:  John N Constantino; Richard D Todd
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

8.  Autism and associated medical disorders in a French epidemiological survey.

Authors:  E Fombonne; C Du Mazaubrun; C Cans; H Grandjean
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-11       Impact factor: 8.829

9.  Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders.

Authors:  C Lord; M Rutter; A Le Couteur
Journal:  J Autism Dev Disord       Date:  1994-10

10.  The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway.

Authors:  Delia M Talos; Hongyu Sun; Xiangping Zhou; Erin C Fitzgerald; Michele C Jackson; Peter M Klein; Victor J Lan; Annelise Joseph; Frances E Jensen
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

View more
  55 in total

Review 1.  Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy.

Authors:  Amy R Brooks-Kayal; Kevin G Bath; Anne T Berg; Aristea S Galanopoulou; Gregory L Holmes; Frances E Jensen; Andres M Kanner; Terence J O'Brien; Vicky H Whittemore; Melodie R Winawer; Manisha Patel; Helen E Scharfman
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

2.  AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures.

Authors:  Jocelyn J Lippman-Bell; Sanjay N Rakhade; Peter M Klein; Makram Obeid; Michele C Jackson; Annelise Joseph; Frances E Jensen
Journal:  Epilepsia       Date:  2013-10-01       Impact factor: 5.864

3.  Neurophysiological indices of atypical auditory processing and multisensory integration are associated with symptom severity in autism.

Authors:  Alice B Brandwein; John J Foxe; John S Butler; Hans-Peter Frey; Juliana C Bates; Lisa H Shulman; Sophie Molholm
Journal:  J Autism Dev Disord       Date:  2015-01

4.  Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice.

Authors:  John J McMahon; Wilson Yu; Jun Yang; Haihua Feng; Meghan Helm; Elizabeth McMahon; Xinjun Zhu; Damian Shin; Yunfei Huang
Journal:  Neurobiol Dis       Date:  2014-10-12       Impact factor: 5.996

5.  Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis.

Authors:  Anita K Chisholm; Vicki A Anderson; Natalie A Pride; Stephanie Malarbi; Kathryn N North; Jonathan M Payne
Journal:  Neuropsychol Rev       Date:  2018-08-11       Impact factor: 7.444

6.  Distribution and Within-Family Specificity of Quantitative Autistic Traits in Patients with Neurofibromatosis Type I.

Authors:  John N Constantino; Yi Zhang; Kieran Holzhauer; Sayli Sant; Kyna Long; Alicia Vallorani; Leena Malik; David H Gutmann
Journal:  J Pediatr       Date:  2015-06-04       Impact factor: 4.406

7.  Epilepsy drives autism in neurodevelopmental disorders.

Authors:  Randi J Hagerman
Journal:  Dev Med Child Neurol       Date:  2013-02       Impact factor: 5.449

Review 8.  A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.

Authors:  David M Feliciano; Tiffany V Lin; Nathaniel W Hartman; Christopher M Bartley; Cathryn Kubera; Lawrence Hsieh; Carlos Lafourcade; Rachel A O'Keefe; Angelique Bordey
Journal:  Int J Dev Neurosci       Date:  2013-02-26       Impact factor: 2.457

Review 9.  Immune dysregulation in autism spectrum disorder.

Authors:  Daniela Briceno Noriega; Huub F J Savelkoul
Journal:  Eur J Pediatr       Date:  2013-12-03       Impact factor: 3.183

10.  Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network.

Authors:  Deborah A Bilder; Amanda V Bakian; David A Stevenson; Paul S Carbone; Christopher Cunniff; Alyson B Goodman; William M McMahon; Nicole P Fisher; David Viskochil
Journal:  J Autism Dev Disord       Date:  2016-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.